Oligonucleotide Solid Phase Synthesizer Market Share Analysis, Demand, Market Growth Forecast, 2021–2032
The Oligonucleotide Solid Phase Synthesizer Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 3.5 billion by 2034, registering a CAGR of 11.5%. This growth trajectory is underpinned by several factors, including advancements in biotechnology, increasing demand for personalized medicine, and the rising prevalence of genetic disorders. The market is witnessing a surge in...
0 Comments 0 Shares 2K Views 0 Reviews